ESGold Announces Brokered LIFE Offering for Gross Proceeds of up to C$7 Million
aTyr PharmaaTyr Pharma(US:LIFE) TMX Newsfile·2026-02-19 12:15

Core Viewpoint - ESGold Corp. has announced a private placement agreement with Red Cloud Securities Inc. to raise gross proceeds of up to C$7,000,600 through the sale of up to 10,295,000 units at a price of C$0.68 per unit [1] Group 1: Offering Details - Each unit consists of one common share and one-half of a common share purchase warrant, with each warrant allowing the purchase of one common share at a price of C$1.00 within 36 months of the closing date [2] - The company grants the agent an option to sell up to an additional 1,471,000 units for up to an additional C$1,000,280 in gross proceeds [3] - The offering is expected to close on March 10, 2026, subject to regulatory approvals [7] Group 2: Use of Proceeds - The net proceeds from the sale of units will be used for advancing the Montauban Project in Québec and for general working capital and corporate purposes [4] Group 3: Regulatory Compliance - The units will be offered to purchasers in specific Canadian provinces under the listed issuer financing exemption and may also be sold in the U.S. and other jurisdictions under applicable laws [5] - The offering document related to the offering is accessible on the company's profile and website [6]

aTyr Pharma-ESGold Announces Brokered LIFE Offering for Gross Proceeds of up to C$7 Million - Reportify